Author(s):
Dheeraj Ahirwar, Bharti Ahirwar
Email(s):
dheeraj_ahirwar@rediffmail.com , ah_bharti@yahoo.com
DOI:
10.5958/0974-360X.2020.00291.7 
Address:
Dheeraj Ahirwar1, Bharti Ahirwar2
1School of Pharmacy, Chouksey Engineering College, Bilaspur, (CG) India 495006.
2Institute of Pharmacy, Guru Ghasidas Central University, Bilaspur (CG) India 495001.
*Corresponding Author
Published In:
Volume - 13,
Issue - 4,
Year - 2020
ABSTRACT:
Nigella sativa (NS) and its seeds have a long history of folkloric uses in all traditional systems of medicines globally for the treatment of various ailments. Therefore, the exploration of the antidepressant activity of this plant is to be the main aim. Nigella sativa seed powder was extracted with alcohol for 3 h in soxhlet. The extract was concentrated in the rotatory evaporator under reduced pressure. DPPH, superoxide radical scavenging, nitric oxide radical scavenging assay, and ABTS assay were carried out for antioxidant activity. The antidepressant activity was performed in stressed mice followed by tail suspension, locomotor activity, and forced swim test. Results indicated the potential antidepressant effect of NS extract in stressed mice, exposed to 6 h immobilizations. Methylene blue and SB-203580 potentiated the effect of sub-doses of NS in stressed mice along with significant antioxidant properties. NS extract also significantly decreased plasma nitric oxide.Seed extract of NS may consider as a new herbal antioxidant and antidepressant agent.
Cite this article:
Dheeraj Ahirwar, Bharti Ahirwar. Antidepressant effect of Nigella sativa in stress-induced depression. Research J. Pharm. and Tech. 2020; 13(4):1611-1614. doi: 10.5958/0974-360X.2020.00291.7
Cite(Electronic):
Dheeraj Ahirwar, Bharti Ahirwar. Antidepressant effect of Nigella sativa in stress-induced depression. Research J. Pharm. and Tech. 2020; 13(4):1611-1614. doi: 10.5958/0974-360X.2020.00291.7 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-4-1
REFERENCES:
1. Andreazza, A.C. Cassini, C. Rosa, A.R. Leite, M.C. De Almeida, L.M. Nardin, P. Cunha, A.B. Cereser, K.M. Santin, A. Gottfried, C. Salvodor, M. Kapczinski, F. Goncalves, C.A. Serum S100B and antioxidant enzymes in bipolar patients, J. Psychiatr. Res. 41:6 (2007) 523 - 529.
2. Andreazza, A.C. Kauer-Sant Anna, M. Frey, B.N. Stertz, L. Zanotto, C. Ribeiro, L. Giasson, K. Valvassori, S.S. Reus, G.Z. Salvador, M. Quevedo, J. Goncalves, C.A. Kapczinski, F. Effects of mood stabilizers on DNA damage in an animal model of mania, J. Psychiatry. Neurosci. 33:6 (2008) 516 - 524.
3. Halliwell, B. Biochemistry of oxidative stress, Biochem. Soc. Trans. 35:5 (2007) 1147 - 1150.
4. Gutteridge, J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage, Clin. Chem. 41:12 (1995) 1819 - 1828.
5. Niki, E. Yoshida, Y. Saito, Y. Noguchi, N. Lipid peroxidation: mechanism, inhibition, and biological effects, Biochem. Biophys. Res. Commun. 338:1 (2005) 668 - 676.
6. Bilici, M. Efe, H. Koroglu, M.A. Uydu, H.A. Bekaroglu, M. Deger, O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J. Affect. Disord. 64:1 (2001) 43 - 51.
7. Brookes, P.S. Yoon, Y. Robotham, J.L. Anders, M.W. Sheu, S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle, Am. J. Physiol. Cell Physiol. 287:4 (2004) 817 - 833.
8. Guzik, T.J. Korbut, R. Adamek-Guzik, T. Nitric oxide and superoxide in inflammation and immune regulation, J. Physiol. Pharmacol. 54:4 (2003) 469 - 487.
9. Galecki, P. Smigielski, J. Florkowski, A. Bobinska, K. Pietras, T. Szemrai, J. Analysis of two polymorphisms of the manganese superoxide dismutase gene (lle-58Thr and Ala-9Val) in patients with recurrent depressive disorder, Psychiatry Res. 179:1 (2010) 43 - 46.
10. Vani, T. Rajani, M. Sarkar, S. Shishoo, C.J. Antioxidant properties of the Ayurvedic formulation triphala and its constituents, Inter. J. Pharmacog. 35:5 (1997) 313 - 317.
11. Gow-Chin, Y. Hui-Yin, C. Antioxidant activity of various tea extracts in relation to their antimutagenicity, J. Agric. Food Chem. 43 (1995) 27 - 32.
12. Sreejavan, Rao, M.N. Oxide scavenging by curcuminoids, J. Pharm. Pharmacol. 49:1 (1997) 105 - 107.
13. Ahirwar, B. Ahirwar, D. Antioxidant and hepatoprotective activity of root extract of Baliospermum montanum (Wild) Muell Arg, RJPT. 12:6 (2019) 2705-2711.
14. Bhattacharya, S.K. and Bhattachatyya, D. Effect of restraint stress on rat brain serotonin, J. Biosci. 4 (1982) 269.
15. Esch, T. Stefano, G.B. Fricchione, G.L. Benson, H. The role of stress in neurodegenerative diseases and mental disorders, Neuroendocrinology Letters 22:3 (2002) 199 - 208.
16. Madrigal, J.L. Hurtado, O. Moro, M.A. Lizasoain, I. Lorenzo, P. Castrillo, A. Boscá, L. Leza, J.C. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress, Neuropsychopharmacology 26:2 (2002) 155 - 163.
17. Cesaris, M. Caillenz, H. Cadet, F. Pabion, M. In vivo analysis of HLA-DQ gene expression in heterozygous cell lines, Immunogentics 50 (1999) 309 - 318.
18. Sevgi, S. Ozek, M. Eroglu, L. L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress, Methods Find Exp. Clin. Pharmacol. 28:2 (2006) 95 - 99.
19. Mutlu, O. Ulak, G. Laugeray, A. Belzung, C. Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice, Pharmacol. Biochem. Behav. 92:1 (2009) 82 – 87.
20. Munhoz, C.D. García-Bueno, B.J.L. Madrigal, L.B. Lepsch, C. Scavone, J.C. Stress-induced neuroinflammation:mechanisms and new pharmacological Targets, Braz. J. Med. Biol. Res. 41:12 (2008) 1037 - 1046.
21. Southam, E. Garthwaile, J. The nitric oxide-cycle GMP signaling pathway in rat brain, Neuropharmacology 32:11 (1993) 1267 - 1277.
22. Eroglu, L. Caglayan, B. Anxiolytic and antidepressant properties of methylene blue in animal models, Pharmacol. Res. 36:5 (1997) 381 - 385.